04.05.2011
- Europe's largest biotech Actelion was dealt a blow when a jury in a Californian court said Japanese drugmaker Asahi Kasei should be awarded up to $547 million in a licensing...
02.05.2011
- Swiss biotech group Actelion is now facing a tougher battle at its annual general meeting this week after a jury decided Asahi Kasei Pharma Corporation should be awarded up to $547...
02.05.2011
- Swiss biotech group Actelion may appeal against a jury's decision in a Californian court to award Asahi Kasei Pharma Corporation up to $547 million in a dispute with Actelion unit...
